Accell is commencing a clinical study in healthy volunteers for a Hepatitis B vaccine. The clinical study has received the approval of Ministry of Health as a part of the medicinal product registration application. The clinical study will recruit 100 subjects in Saint Petersburg, Russia. We will perform data management and statistical analysis of the clinical study data, and the final study report will be used to obtain the registration of the vaccine on the Russian market.